Neurology Academy’s Post

Biomarker science continues to move forward.

Did you know that June is Alzheimers Awareness month? Check this article out for a fascinating update in Alzheimer's disease research, and how machine learning helped contribute to the discovery! #ArtemisFactor #Pharma #AlzheimersAwareness #MachineLearning #HealthcareInnovation #PharmaLeadership #ProjectManagement #WomenOwnedBusiness

Very excited to share this study: we propose that transcriptional subtyping may enhance precision prognosis and therapy stratification in MYCN non-amplified neuroblastomas. https://lnkd.in/ekKV8Zhg

The access to real time data at the individual level is propelling the growth of the digital biomarker space. This is a solution to track progression of Parkinson’s and other neurological conditions

On World Parkinson's Day, we're excited to share groundbreaking research being conducted using our human-based in-vitro model, the NeuroHTS™ platform.   🔬 Research Breakthrough: Using the NeuroHTS™ platform, we organize hiPSC neurons derived from healthy individuals and Parkinson's disease (PD) donors into standardized networks. Our proprietary software compares over 3,000 data points of the network's morphology from a single assay, enabling us to identify key differences and pathways affected in cells from Parkinson's disease.   💡 Rapid Drug Screening: We leverage this cutting-edge technology as a rapid and reliable drug screening tool to differentiate the effects of therapeutic candidates for Parkinson's Disease and identify those that can significantly improve the morphology of neuronal networks from a Parkinson’s patient in a dose-responsive manner. Our assays streamline the drug development pipeline, optimizing resource allocation and focusing on advancing treatments for Parkinson's Disease.   🌟 Our Mission: Our aim is to consistently deliver fast, reliable, scalable, and physiologically relevant results to help de-risk early-stage drug development in neurodegenerative diseases. We are committed to making a meaningful impact in the lives of individuals living with Parkinson's disease and their families by accelerating the development of innovative treatments.   Join us in celebrating the progress we've made and continue to make in the fight against Parkinson's disease. #WorldParkinsonsDay #ParkinsonsAwareness #NeuroHTS #Innovation #Research #DrugDevelopment #HopeForPD

A clinical trial is set to employ advanced, non-invasive ultrasound technology to gain deeper insights into the molecular mechanisms behind the development and progression of Parkinson's disease. #ClinicalTrials #UltrasoundTechnology #ParkinsonsDisease #MedicalResearch #NonInvasive

For those of you following #alzheimersdisease, this one for you! Sometimes you ask yourself what is science doing to help me, well this work below is what is happening. We are thinking about each of you and we have innovations that will help in the future. Keep supporting scientist and the brilliant work they do. #alzheimersresearch #spatialbiology #innovation

In a groundbreaking discovery, scientists at University of Amsterdam have identified five distinct biological variants of Alzheimer's disease through cerebrospinal fluid analysis. The implications for personalized medicine in Alzheimer's treatment are profound – tailored therapies based on these variants could significantly enhance drug effectiveness. This research challenges the notion of one-size-fits-all treatments, emphasizing the need for precision medicine to improve outcomes and minimize side effects for Alzheimer's patients. Read more about the study here: https://lnkd.in/e4b-xcPx #alzheimersresearch #precisionmedicine

Advancement in Parkinson’s Disease Prediction with AI-Powered Blood Test 🔬 A groundbreaking blood test that predicts Parkinson’s disease up to seven years before symptoms manifest have been developed. Utilizing artificial intelligence to analyze eight blood biomarkers, this test has achieved a remarkable 100% accuracy rate. 💡 Early Intervention Potential: This innovation opens doors for early treatment options, potentially safeguarding dopamine-producing brain cells before significant damage occurs. 🧬 Research Insights: The test accurately identified Parkinson’s in patients and classified 79% of individuals with REM sleep behavior disorder as at risk, up to seven years prior to symptom onset. 🌐 For more details on this revolutionary discovery, check out the full research in Nature Communications - link: https://lnkd.in/d78jYm-S #ParkinsonsDisease #BiomarkerforParkinsons

new definitive molecule for Alzheimer? This study allows us to see the innovative molecule against tau-protein with a double targeting approach. To know more, there is the article!